Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Randomised, Single-site Trial on the Minimisation of Immunosuppression In Elderly Renal Transplant Recipients.

NCT05073822 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT05073822
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05073822 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Randomised, Single-site Trial on the Minimisation of Immunosuppression In Elderly Renal Transplant Recipients.
Lead sponsor
University College, London
Phase
Phase 1/2
Overall status
Withdrawn
Start date
February 20, 2023
Completion date
February 20, 2027
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

renal transplant infection, renal transplant rejection